Evidence map›Paper›PMID 40686513›Full record

ArticleUrology case reports2025

Recurrent prostatic stromal sarcoma (PSS): A case report and literature review.

Mohammad Reza Nowroozi, Mohammad Hamidi Madani, Amirreza Farzin, Saeed Montazeri, Zahra Tahamtani Torkamani, Ehsan Hajiasadi

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Urology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohammad Reza NowrooziUro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Hamidi MadaniUro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Amirreza FarzinUro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Saeed MontazeriUro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Zahra Tahamtani TorkamaniUro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Ehsan HajiasadiUro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostatic stromal sarcoma (PSS) is an exceptionally rare mesenchymal tumor of the prostate. We present a case of high-grade recurrent PSS in a 49-year-old man, managed with complete surgical excision and successful organ preservation. This report is accompanied by a literature review highlighting diagnostic challenges, histopathological features, and evolving surgical approaches, including robotic-assisted techniques. By comparing our case with previously reported cases, we emphasize the importance of individualized treatment strategies and long-term follow-up in managing this aggressive malignancy.

Indexed as

HematuriaHistopathologyMagnetic resonance imagingMesenchymal tumorPelvic massProstatic stromal sarcoma

Identifiers

PMID40686513
PMCPMC12272748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.